Fusion Pharmaceuticals Inc. Common Shares
FUSN
FUSN was delisted on the 3rd of June, 2024.
38 hedge funds and large institutions have $296M invested in Fusion Pharmaceuticals Inc. Common Shares in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 5 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 37 → 38 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8% less capital invested
Capital invested by funds: $320M → $296M (-$24.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$8.58M |
| 2 |
AG
Artal Group
Luxembourg
|
+$6.3M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.34M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$1.24M |
| 5 |
SCM
Sio Capital Management
New York
|
+$897K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASP
Adams Street Partners
Chicago,
Illinois
|
-$5.88M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$4.69M |
| 3 |
PA
Perceptive Advisors
New York
|
-$3.34M |
| 4 |
DM
Deerfield Management
New York
|
-$1.91M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$588K |
FUSN Hedge Fund Activity: Q1 2021 in Review
38 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Fusion Pharmaceuticals Inc. Common Shares (FUSN) for Q1 2021, worth a combined $296M — down 7.5% from $320M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new FUSN positions and 5 closed out — a net gain of 1 holder — while 10 added to existing stakes and 8 trimmed.
The largest buyer was 1832 Asset Management, opening a new position worth an estimated $8.58M. The largest seller was Adams Street Partners, cutting an estimated $5.88M.
- 38 institutional investors held Fusion Pharmaceuticals Inc. Common Shares (FUSN) as of Q1 2021, up from 37 in Q4 2020.
- Funds reported $296M of Fusion Pharmaceuticals Inc. Common Shares stock for Q1 2021, down 7.5% quarter-over-quarter.
- 6 funds opened new Fusion Pharmaceuticals Inc. Common Shares positions in Q1 2021 and 5 closed out, a net change of +1 holder.
- The largest Fusion Pharmaceuticals Inc. Common Shares buyer in Q1 2021 was 1832 Asset Management, an estimated $8.58M added.
- The largest Fusion Pharmaceuticals Inc. Common Shares seller in Q1 2021 was Adams Street Partners, an estimated $5.88M sold.
Based on aggregated 13F filings for Q1 2021.